Does UMECLIDINIUM Cause Nasal polyps? 211 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 211 reports of Nasal polyps have been filed in association with UMECLIDINIUM (Anoro Ellipta). This represents 3.3% of all adverse event reports for UMECLIDINIUM.
211
Reports of Nasal polyps with UMECLIDINIUM
3.3%
of all UMECLIDINIUM reports
0
Deaths
112
Hospitalizations
How Dangerous Is Nasal polyps From UMECLIDINIUM?
Of the 211 reports, 112 (53.1%) required hospitalization.
Is Nasal polyps Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UMECLIDINIUM. However, 211 reports have been filed with the FAERS database.
What Other Side Effects Does UMECLIDINIUM Cause?
Dyspnoea (1,817)
Asthma (1,433)
Wheezing (1,111)
Therapeutic product effect incomplete (980)
Cough (913)
Drug ineffective (734)
Loss of personal independence in daily activities (711)
Obstructive airways disorder (654)
Chronic obstructive pulmonary disease (588)
Condition aggravated (580)
What Other Drugs Cause Nasal polyps?
DUPILUMAB (1,391)
ALBUTEROL (915)
PREDNISONE (780)
MEPOLIZUMAB (702)
MONTELUKAST (622)
OMALIZUMAB (544)
BUDESONIDE\FORMOTEROL (486)
TIOTROPIUM (400)
BUDESONIDE (397)
FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (311)
Which UMECLIDINIUM Alternatives Have Lower Nasal polyps Risk?
UMECLIDINIUM vs UMECLIDINIUM\VILANTEROL TRIFENATATE
UMECLIDINIUM vs UMIFENOVIR
UMECLIDINIUM vs UNSPECIFIED INGREDIENT
UMECLIDINIUM vs UPADACITINIB
UMECLIDINIUM vs URAPIDIL